Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 3,219 | 3,368 | 529 | 614 | -4,591 |
| Operating Income | -3,219 | -3,368 | -529 | -614 | 4,591 |
| Other Income | 2 | 1 | 13 | 2 | 78 |
| Pre-tax Income | -3,216 | -3,367 | -516 | -612 | 4,669 |
| Net Income Continuous | -3,216 | -3,367 | -516 | -612 | 4,776 |
| Net Income | $-3,216 | $-3,367 | $-516 | $-612 | $4,776 |
| EPS Basic Total Ops | -14.01 | -22.69 | -7.56 | -8.68 | 257.98 |
| EPS Basic Continuous Ops | -13.99 | -22.56 | -7.42 | -8.82 | 257.97 |
| EPS Diluted Total Ops | -14.01 | -22.69 | -7.56 | -8.68 | 257.98 |
| EPS Diluted Continuous Ops | -13.99 | -22.56 | -7.42 | -8.82 | 257.97 |
| EBITDA(a) | $-3,218 | $-3,368 | $-528 | $-614 | $4,591 |